Skip to main content
Top
Published in: Supportive Care in Cancer 11/2012

01-11-2012 | Original Article

Symptom clusters in patients with bone metastases—a reanalysis comparing different statistical methods

Authors: Emily Chen, Luluel Khan, Liying Zhang, Janet Nguyen, Gemma Cramarossa, May Tsao, Cyril Danjoux, Elizabeth Barnes, Arjun Sahgal, Lori Holden, Flo Jon, Kristopher Dennis, Shaelyn Culleton, Edward Chow

Published in: Supportive Care in Cancer | Issue 11/2012

Login to get access

Abstract

Purpose

The aims of this study were to determine whether symptom clusters in patients with bone metastases varied when derived using three different statistical methods and to compare the presentation of symptom clusters over time in responders and nonresponders to palliative radiation treatment (RT).

Methods

Secondary analysis of a previously reported data set compiled using the brief pain inventory from 348 patients with bone metastases. Hierarchical cluster analysis (HCA) and exploratory factor analysis (EFA) were performed to identify symptom clusters at baseline, 1, 2, and 3 months following radiation treatment. Clusters derived were compared with the findings obtained using principal component analysis (PCA) in our previous study. The total patient sample was further separated into two subgroups: responders and nonresponders to RT. PCA, HCA, and EFA identified symptom clusters experienced by each subgroup at the same time points as before.

Results

Little correlation was observed in the symptom cluster findings of PCA, EFA, and HCA in the total patient sample. Absolute consensus among all three statistical methods was never reached at any assessment time point in the present study. Varying patterns of symptom cluster presentation over time were observed in the responders versus nonresponders subgroups regardless of the analytical method employed. A core cluster of symptoms composed of worst pain, general activity, walking ability, normal work, and enjoyment of life frequently presented in the same cluster.

Conclusion

The presence and composition of symptom clusters derived varied depending on which statistical analysis method was employed. A key step in attaining consistency in symptom cluster research necessitates the utilization of a common method.
Appendix
Available only for authorised users
Literature
2.
go back to reference Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed
3.
go back to reference Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270–282, quiz 283-4, quiz 283-4PubMedCrossRef Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270–282, quiz 283-4, quiz 283-4PubMedCrossRef
4.
go back to reference Paice JA (2004) Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monogr 32:98–102PubMedCrossRef Paice JA (2004) Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monogr 32:98–102PubMedCrossRef
5.
go back to reference Henoch I, Ploner A, Tishelman C (2009) Increasing stringency in symptom cluster research: a methodological exploration of symptom clusters in patients with inoperable lung cancer. Oncol Nurs Forum 36(6):E282–E292PubMedCrossRef Henoch I, Ploner A, Tishelman C (2009) Increasing stringency in symptom cluster research: a methodological exploration of symptom clusters in patients with inoperable lung cancer. Oncol Nurs Forum 36(6):E282–E292PubMedCrossRef
6.
go back to reference Hadi S, Fan G, Hird AE, Kirou-Mauro A, Filipczak LA, Chow E (2008) Symptom clusters in patients with cancer with metastatic bone pain. J Palliat Med 11(4):591–600PubMedCrossRef Hadi S, Fan G, Hird AE, Kirou-Mauro A, Filipczak LA, Chow E (2008) Symptom clusters in patients with cancer with metastatic bone pain. J Palliat Med 11(4):591–600PubMedCrossRef
7.
go back to reference Xiao C (2010) The state of science in the study of cancer symptom clusters. Eur J Oncol Nurs 14(5):417–434PubMedCrossRef Xiao C (2010) The state of science in the study of cancer symptom clusters. Eur J Oncol Nurs 14(5):417–434PubMedCrossRef
8.
go back to reference Donovan KA, Jacobsen PB, Andrykowski MA, Winters EM, Balducci L, Malik U et al (2004) Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manag 28(4):373–380CrossRef Donovan KA, Jacobsen PB, Andrykowski MA, Winters EM, Balducci L, Malik U et al (2004) Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manag 28(4):373–380CrossRef
9.
go back to reference Glaus A, Boehme C, Thurlimann B, Ruhstaller T, Hsu Schmitz SF, Morant R et al (2006) Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 17(5):801–806PubMedCrossRef Glaus A, Boehme C, Thurlimann B, Ruhstaller T, Hsu Schmitz SF, Morant R et al (2006) Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 17(5):801–806PubMedCrossRef
10.
go back to reference Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR et al (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46PubMedCrossRef Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR et al (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46PubMedCrossRef
11.
go back to reference Kim HJ, Abraham IL (2008) Statistical approaches to modeling symptom clusters in cancer patients. Cancer Nurs 31(5):E1–E10PubMedCrossRef Kim HJ, Abraham IL (2008) Statistical approaches to modeling symptom clusters in cancer patients. Cancer Nurs 31(5):E1–E10PubMedCrossRef
12.
go back to reference Lesch C, Jo J, Wu Y, Fish GS, Galko MJ (2010) A targeted UAS-RNAi screen in Drosophila larvae identifies wound closure genes regulating distinct cellular processes. Genetics 186(3):943–957PubMedCrossRef Lesch C, Jo J, Wu Y, Fish GS, Galko MJ (2010) A targeted UAS-RNAi screen in Drosophila larvae identifies wound closure genes regulating distinct cellular processes. Genetics 186(3):943–957PubMedCrossRef
13.
go back to reference Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manag 31(1):85–95CrossRef Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manag 31(1):85–95CrossRef
14.
go back to reference Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64(3):275–280PubMedCrossRef Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64(3):275–280PubMedCrossRef
15.
go back to reference Maliski SL, Kwan L, Elashoff D, Litwin MS (2008) Symptom clusters related to treatment for prostate cancer. Oncol Nurs Forum 35(5):786–793PubMedCrossRef Maliski SL, Kwan L, Elashoff D, Litwin MS (2008) Symptom clusters related to treatment for prostate cancer. Oncol Nurs Forum 35(5):786–793PubMedCrossRef
16.
go back to reference Gleason JF Jr, Case D, Rapp SR, Ip E, Naughton M, Butler JM Jr et al (2007) Symptom clusters in patients with newly-diagnosed brain tumors. J Support Oncol 5(9):427–433, 436PubMed Gleason JF Jr, Case D, Rapp SR, Ip E, Naughton M, Butler JM Jr et al (2007) Symptom clusters in patients with newly-diagnosed brain tumors. J Support Oncol 5(9):427–433, 436PubMed
17.
18.
go back to reference Skerman HM, Yates PM, Battistutta D (2009) Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 32(3):345–360PubMedCrossRef Skerman HM, Yates PM, Battistutta D (2009) Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 32(3):345–360PubMedCrossRef
19.
go back to reference Xu MJ, Chen N, Song HQ, Lin RQ, Huang CQ, Yuan ZG et al (2010) RNAi-mediated silencing of a novel Ascaris suum gene expression in infective larvae. Parasitol Res 107(6):1499–1503PubMedCrossRef Xu MJ, Chen N, Song HQ, Lin RQ, Huang CQ, Yuan ZG et al (2010) RNAi-mediated silencing of a novel Ascaris suum gene expression in infective larvae. Parasitol Res 107(6):1499–1503PubMedCrossRef
20.
go back to reference Stevens J (2002) Applied Multivariate Statistics for the Social Sciences (4th Edition). Mahwah, NJ: Lawrence Erlbaum Associates, pp 395 Stevens J (2002) Applied Multivariate Statistics for the Social Sciences (4th Edition). Mahwah, NJ: Lawrence Erlbaum Associates, pp 395
21.
go back to reference Bartlett MS (1937) Properties of sufficiency and statistical tests. Proceedings of the Royal Statistical Society Series 160(A):268–282 Bartlett MS (1937) Properties of sufficiency and statistical tests. Proceedings of the Royal Statistical Society Series 160(A):268–282
Metadata
Title
Symptom clusters in patients with bone metastases—a reanalysis comparing different statistical methods
Authors
Emily Chen
Luluel Khan
Liying Zhang
Janet Nguyen
Gemma Cramarossa
May Tsao
Cyril Danjoux
Elizabeth Barnes
Arjun Sahgal
Lori Holden
Flo Jon
Kristopher Dennis
Shaelyn Culleton
Edward Chow
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1403-1

Other articles of this Issue 11/2012

Supportive Care in Cancer 11/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine